Table 1.
Neuroimaging technologies
|
Methods/measures
|
Relatively consistent findings
|
fMRI | Functional connectivity strength | Changes in cingulate cortex, frontal cortex, and left angel gyrus |
Functional activity of local brain regions | Changes in cingulate cortex and prefrontal cortex | |
PET | Neurotransmitters | Downregulation of brain serotonin receptors |
Glucose metabolism | Reduction in glucose metabolism after ECT in bilateral anterior and posterior frontal areas | |
MRS | Gln/Glx, GABA, NAA, Cho, mI, Cr | None |
sMRI | Gray matter volumn | Increase in hippocampus and amygdala |
DTI | White matter | Alterations in microstructure and pathways |
fMRI: Functional magnetic resonance imaging; PET: Positron emission tomography; MRS: Magnetic resonance spectroscopy; sMRI: Structural magnetic resonance imaging; DTI: Diffusion tensor imaging; Gln: Glutamine; Glx: Glutamate and Gln; GABA: γ-aminobutyric acid; NAA: N-acetyl-L-aspartic acid; Cho: Choline-containing compounds; mI: Myoinositol; Cr: Creatine; ECT: Electroconvulsive therapy.